Literature DB >> 17517607

Development of autoimmunity in mice lacking DNA topoisomerase 3beta.

Kelvin Y Kwan1, Rebecca J Greenwald, Subhasis Mohanty, Arlene H Sharpe, Albert C Shaw, James C Wang.   

Abstract

Mice lacking DNA topoisomerase 3beta are predisposed to a shortened lifespan, infertility, and lesions in multiple organs resulting from inflammatory responses. Examination of the immune system of 6- and 52-week-old top3beta(-/-) mice revealed no significant aberrations in their central and peripheral tolerance or in T lymphocyte activation. However, the older but not the younger cohort shows a high incidence of serum autoantibodies relative to their TOP3beta(+/+) age-mates. The mutant mice also show an increase in numerical aberrations of chromosomes in splenocytes and bone marrow cells, as well as an increase in apoptotic cells in the thymus. Thus, it appears plausible that the inflammatory lesions in top3beta(-/-) mice are caused by the development of autoimmunity as they age: Chromosomal abnormalities in top3beta(-/-) mice might lead to a persistent increase in apoptotic cells, which might in turn lead to the progression of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517607      PMCID: PMC1890479          DOI: 10.1073/pnas.0703587104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

Review 1.  Hyper-recombination and Bloom's syndrome: microbes again provide clues about cancer.

Authors:  R Rothstein; S Gangloff
Journal:  Genome Res       Date:  1995-12       Impact factor: 9.043

2.  The Bloom's syndrome gene product is homologous to RecQ helicases.

Authors:  N A Ellis; J Groden; T Z Ye; J Straughen; D J Lennon; S Ciocci; M Proytcheva; J German
Journal:  Cell       Date:  1995-11-17       Impact factor: 41.582

3.  Positional cloning of the Werner's syndrome gene.

Authors:  C E Yu; J Oshima; Y H Fu; E M Wijsman; F Hisama; R Alisch; S Matthews; J Nakura; T Miki; S Ouais; G M Martin; J Mulligan; G D Schellenberg
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

4.  Yeast Rmi1/Nce4 controls genome stability as a subunit of the Sgs1-Top3 complex.

Authors:  Janet R Mullen; Ferez S Nallaseth; Yan Q Lan; Christopher E Slagle; Steven J Brill
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

5.  A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase.

Authors:  J W Wallis; G Chrebet; G Brodsky; M Rolfe; R Rothstein
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

6.  The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase.

Authors:  S Gangloff; J P McDonald; C Bendixen; L Arthur; R Rothstein
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 7.  Bloom's syndrome.

Authors:  J German
Journal:  Dermatol Clin       Date:  1995-01       Impact factor: 3.478

8.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

9.  Three-dimensional structure of the 67K N-terminal fragment of E. coli DNA topoisomerase I.

Authors:  C D Lima; J C Wang; A Mondragón
Journal:  Nature       Date:  1994-01-13       Impact factor: 49.962

10.  A case of Werner's syndrome associated with systemic lupus erythematosus.

Authors:  A Kogure; Y Ohshima; N Watanabe; T Ohba; M Miyata; M Ohara; T Nishimaki; R Kasukawa
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

View more
  16 in total

1.  Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation.

Authors:  Yanzhong Yang; Kevin M McBride; Sean Hensley; Yue Lu; Frederic Chedin; Mark T Bedford
Journal:  Mol Cell       Date:  2014-02-06       Impact factor: 17.970

Review 2.  The many lives of type IA topoisomerases.

Authors:  Anna H Bizard; Ian D Hickson
Journal:  J Biol Chem       Date:  2020-04-10       Impact factor: 5.157

3.  Molecular Evolution of DNA Topoisomerase III Beta (TOP3B) in Metazoa.

Authors:  Filipa Moreira; Miguel Arenas; Arnaldo Videira; Filipe Pereira
Journal:  J Mol Evol       Date:  2021-05-17       Impact factor: 2.395

4.  An Assay for Detecting RNA Topoisomerase Activity.

Authors:  Muzammil Ahmad; Dongyi Xu; Weidong Wang
Journal:  Methods Mol Biol       Date:  2018

5.  Defective p53 engagement after the induction of DNA damage in cells deficient in topoisomerase 3beta.

Authors:  Subhasis Mohanty; Terrence Town; Tomohito Yagi; Christina Scheidig; Kelvin Y Kwan; Heather G Allore; Richard A Flavell; Albert C Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

Review 6.  Unravelling the mechanisms of Type 1A topoisomerases using single-molecule approaches.

Authors:  Dian Spakman; Julia A M Bakx; Andreas S Biebricher; Erwin J G Peterman; Gijs J L Wuite; Graeme A King
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

7.  Methanosarcina acetivorans C2A topoisomerase IIIα, an archaeal enzyme with promiscuity in divalent cation dependence.

Authors:  Raymond Morales; Palita Sriratana; Jing Zhang; Isaac K O Cann
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

8.  Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction.

Authors:  Muzammil Ahmad; Weiping Shen; Wen Li; Yutong Xue; Sige Zou; Dongyi Xu; Weidong Wang
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

9.  Structural basis of the interaction between Topoisomerase IIIβ and the TDRD3 auxiliary factor.

Authors:  Sakurako Goto-Ito; Atsushi Yamagata; Tomio S Takahashi; Yusuke Sato; Shuya Fukai
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

10.  Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation.

Authors:  Dongyi Xu; Weiping Shen; Rong Guo; Yutong Xue; Wei Peng; Jian Sima; Jay Yang; Alexei Sharov; Subramanya Srikantan; Jiandong Yang; David Fox; Yong Qian; Jennifer L Martindale; Yulan Piao; James Machamer; Samit R Joshi; Subhasis Mohanty; Albert C Shaw; Thomas E Lloyd; Grant W Brown; Minoru S H Ko; Myriam Gorospe; Sige Zou; Weidong Wang
Journal:  Nat Neurosci       Date:  2013-08-04       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.